checkAd
    Startseite > Aktien > Elevai Labs Regsitered > Nachrichten
    Elevai Labs Regsitered Aktie
    0,6400
     
    USD
    -4,21 %
    -0,0281 USD
    Letzter Kurs 02:00:00 NYSE
    0,6325
     
    USD
    100 STK
    Geldkurs 28.05.24
    0,6889
     
    USD
    100 STK
    Briefkurs 28.05.24
    ISIN: US28622K1043 · WKN: A3EB4B · SYM: ELAB · USA

    Neueste Nachrichten

    Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
    22.05.24 · globenewswire · Elevai Labs Regsitered
    Elevai Labs Inc. Reports First Quarter 2024 Financial Results
    15.05.24 · globenewswire · Elevai Labs Regsitered
    Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
    02.05.24 · globenewswire · Elevai Labs Regsitered
    Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
    01.05.24 · globenewswire · Elevai Labs Regsitered
    Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
    01.05.24 · globenewswire · Elevai Labs Regsitered
    Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
    29.04.24 · globenewswire · Elevai Labs Regsitered
    ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
    22.04.24 · globenewswire · Elevai Labs Regsitered
    Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
    29.03.24 · globenewswire · Elevai Labs Regsitered
    Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
    18.03.24 · globenewswire · Elevai Labs Regsitered
    ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
    24.01.24 · globenewswire · Elevai Labs Regsitered
    ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
    17.01.24 · globenewswire · Elevai Labs Regsitered
    ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing Technology
    16.01.24 · globenewswire · Elevai Labs Regsitered